Year All2024202320222021202020192018201720162015 Poseida Therapeutics Presents Encouraging Preclinical Data Across its CAR-T and Gene Therapy Programs at the American Society of Gene and Cell Therapy 2021 Virtual Annual Meeting May 11, 2021 Poseida Therapeutics Announces Key Additions to Immuno-Oncology Scientific Advisory Board May 6, 2021 Poseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care Conference May 5, 2021 Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting April 27, 2021 Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences April 8, 2021 Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board March 23, 2021 Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 March 11, 2021 Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day February 24, 2021 Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021 February 10, 2021 Poseida Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day February 4, 2021
Poseida Therapeutics Presents Encouraging Preclinical Data Across its CAR-T and Gene Therapy Programs at the American Society of Gene and Cell Therapy 2021 Virtual Annual Meeting May 11, 2021
Poseida Therapeutics Announces Key Additions to Immuno-Oncology Scientific Advisory Board May 6, 2021
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting April 27, 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board March 23, 2021
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 March 11, 2021
Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day February 24, 2021
Poseida Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day February 4, 2021
